Drug search by name

Mogamulizumab-kpkc and Autoimmune disease

Result of checking the interaction of drug Mogamulizumab-kpkc and disease Autoimmune disease for safety when used together.

Check result:

Mogamulizumab-kpkc <> Autoimmune disease

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Fatal and life-threatening immune-mediated complications have been reported in recipients of mogamulizumab. Grade 3 or higher immune-mediated or possibly immune-mediated reactions have included myositis, myocarditis, polymyositis, hepatitis, pneumonitis, and a variant of Guillain- Barré syndrome. Interrupt or permanently discontinue therapy as appropriate for suspected immune-mediated adverse reactions. Consider the benefit/risk of using mogamulizumab in patients with a history of autoimmune disease.

Mogamulizumab-kpkc

Generic Name: mogamulizumab

Brand Name: Poteligeo

Synonyms: Mogamulizumab

What is Mogamulizumab-kpkc?